Proceeds from collaborators
Proceeds from Collaborators
Shares of common stock in connection with securities purchase agreements
Shares of Common Stock to be Purchased by Common Stock Warrants
Shares of Common Stock to be Purchased by Common Stock Warrants
Accrued expenses
Total accrued expenses
Accrued Liabilities, Current
Payments for loan acquisition costs
Payments of Loan Costs
Statistical Measurement [Domain]
Statistical Measurement [Domain]
Statistical Measurement [Domain]
Lincoln Park Agreement, Commitment Share
Lincoln Park Agreement, Commitment Share [Member]
Lincoln Park Agreement, Commitment Share
Research and development
Research and Development Expense
Changes in operating assets and liabilities:
Increase (Decrease) in Operating Capital [Abstract]
Interest and other income (expense), net
Interest And Other Income, Net
Interest And Other Income, Net
Revenue
Revenue from External Customers by Products and Services [Table Text Block]
Award Type [Domain]
Award Type [Domain]
Unvested, at beginning of period (in shares)
Unvested, at end of period (in shares)
Unvested (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Remaining lease term
Lessee, Operating Lease, Remaining Lease Term
12.5% Senior Secured Notes and Loans Payable
Debt Disclosure [Text Block]
Statement of Stockholders' Equity [Abstract]
Statement of Stockholders' Equity [Abstract]
Exercise of warrants (in shares)
Class of Warrant or Right, Warrants Exercised
The number of class of warrant or right exercised.
Accrued balances - accounts payable and accrued expense
Accounts Receivable Allowances and Accruals, Accounts Payable and Accrued Expenses
For an unclassified balance sheet, a valuation of sales allowance for receivables due a company that are expected to be uncollectible, classified within Accounts payable and other accrued expenses.
Royalty receivable
Cumulative Royalty Receivable
Cumulative sum of the carrying amounts of royalty receivable as of the balance sheet date.
Number of guaranteed royalty payments
Number Of Guaranteed Royalty Payments
Number Of Guaranteed Royalty Payments
Performance Shares
Performance Shares [Member]
Accounts payable
Accounts Payable, Current
Royalty Obligation Activity
Royalty Obligation Activity [Table Text Block]
Royalty Obligation Activity
Number of cases pending
Loss Contingency, Pending Claims, Number
Changes in Allowance for Bad Debt
Financing Receivable, Current, Allowance for Credit Loss [Table Text Block]
Contingencies (Note 19)
Commitments and Contingencies
At-the-market offering
At The Market Offering [Member]
At The Market Offering
Exercisable at end of period (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Disaggregation of Revenue [Line Items]
Disaggregation of Revenue [Line Items]
Restricted Stock Units Awards
Nonvested Restricted Stock Shares Activity [Table Text Block]
Computer, network equipment and software
Computer, Network Equipment and Software [Member]
Assets which are related to computer, network equipment and software.
Net proceeds from initial public offering
Proceeds from Issuance of Common Stock
Geographical [Axis]
Geographical [Axis]
Loans payable, current
Loans Payable, Current
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Income Taxes
Income Tax Disclosure [Text Block]
Expected dividend yield
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate
2027 and thereafter
Lessee, Operating Lease, Liability, to be Paid, Year Four And Thereafter
Lessee, Operating Lease, Liability, to be Paid, Year Four And Thereafter
Vested restricted stock units (in shares)
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures
Concentration Risk [Line Items]
Concentration Risk [Line Items]
Elective redemption percentage of debt
Elective redemption percentage of debt
Elective redemption percentage of debt.
Customer [Axis]
Customer [Axis]
Current liabilities:
Liabilities, Current [Abstract]
Pre-Funded Warrants
Pre-Funded Warrants [Member]
Pre-Funded Warrants
Senior secured notes due 2025 - first additional offering
First Additional Offering [Member]
The first additional offering of the loan agreement.
Subsequent Event Type [Domain]
Subsequent Event Type [Domain]
Weighted Average Grant Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Earnings (loss) per share attributable to common stockholders - diluted (in dollars per share)
Earnings Per Share, Diluted
Class of Warrant or Right [Line Items]
Class of Warrant or Right [Line Items]
Eighth Month
Eighth Month [Member]
Eighth Month
Vested restricted stock units
APIC, Share-Based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition
Property, Plant and Equipment [Table]
Property, Plant and Equipment [Table]
Vested or expected to vest at end of period (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Outstanding (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Litigation Case [Axis]
Litigation Case [Axis]
Trading Symbol
Trading Symbol
Liability related to the sale of future revenue, net at December 31, 2022
Liability related to the sale of future revenue, net (includes current portion of $1,000)
Liabilities, Sale of Future Royalties
Liabilities, Sale of Future Royalties
Premium on early retirement of debt
Premiums Paid, Early Retirement of Debt
Premiums Paid, Early Retirement of Debt
Granted (in dollars per share)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Weighted average grant date fair value (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Fair value of put option
Long-Term Debt, Fair Value
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Net income (loss)
Net income (loss)
Net loss
Net Income (Loss)
Total current liabilities
Liabilities, Current
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Abstract]
Machinery
Machinery and Equipment [Member]
Right-of-Use Assets and Lease Obligations
Lessee, Operating Leases [Text Block]
Acquired Finite-Lived Intangible Assets [Line Items]
Acquired Finite-Lived Intangible Assets [Line Items]
Number of annual royalty payments receivable
Number of Annual Royalty Payments Receivable
Number of annual royalty payments receivable by the entity for the use of its rights and property by another party.
Liabilities and stockholders’ deficit
Liabilities and Equity [Abstract]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets [Line Items]
Employee stock purchase plan (ESPP)
Employee Stock [Member]
Private equity
Private equity [Member]
Private equity
Stockholders’ deficit:
Equity, Attributable to Parent [Abstract]
Other
Other Assets, Miscellaneous, Noncurrent
Concentration Risk Benchmark [Domain]
Concentration Risk Benchmark [Domain]
Contract liabilities
Contract with Customer, Liability
Warrants issued to purchase common stock (in shares)
Class Of Warrant Or Right Warrants Issued During Period
The number of warrants issued during the period.
Net proceeds
Net Proceeds After Placement Agent Fees, Expenses, and Offering Expenses Payable
Net Proceeds After Placement Agent Fees, Expenses, and Offering Expenses Payable
Basic and Diluted Net Loss Per Share
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Manufacture and supply
Cost of Goods and Services Sold
Number of Units
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Automatic renewal period of agreement
Automatic Renewal Period of Agreement
Period for which the agreement is renewed automatically.
Summary of Significant Accounting Policies
Significant Accounting Policies [Text Block]
Purchased patent
Patents [Member]
Vested and expected to vest at end of period (in dollars per share)
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments, Other Than Options Grants, Estimated Grant Date Fair Value
The estimated fair value of nonvested equity-based awards on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan) as of grant date.
Property and Equipment, Net
Property, Plant and Equipment [Table Text Block]
Equity Components [Axis]
Equity Components [Axis]
Warrant exercise price (in dollars per share)
Class of Warrant or Right, Exercise Price of Warrants or Rights
Warrants [Abstract]
Warrants Liability [Abstract]
Lessee, Lease, Description [Table]
Lessee, Lease, Description [Table]
Fair value of warrants issued
Adjustments to Additional Paid in Capital, Fair Value of Warrants Issued
Amount of increase in additional paid in capital (APIC) resulting from the issuance of fair value of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.
2025
Long-Term Debt, Maturity, Year Two
Granted (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Entity Small Business
Entity Small Business
Balance at December 31. 2022
Balance at March 31, 2023
Accounts Receivable Allowances and Accruals
For an unclassified balance sheet, a valuation of sales allowance for receivables due a company that are expected to be uncollectible and accruals.
Local Phone Number
Local Phone Number
Remainder of 2023
Long-Term Debt, Maturity, Remainder of Fiscal Year
Receivables
Accounts Receivable [Member]
Warrants on common shares outstanding
Warrant [Member]
Lease liabilities
Operating Lease, Liability, Noncurrent
Company Overview and Basis of Presentation
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]
Restricted stock units
Restricted Stock Units (RSUs) [Member]
Class of Warrant or Right [Table]
Class of Warrant or Right [Table]
Payments for stock issuance costs
Payments of Stock Issuance Costs
Depreciation
Depreciation
Debt Instrument, Name [Domain]
Debt Instrument, Name [Domain]
Indivior
Commercial exploitation agreement with Indivior
Commercial Exploitation Agreement with Indivior [Member]
The commercial exploitation agreement with Indivior.
Income Statement Location [Axis]
Income Statement Location [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Unamortized deferred debt issuance cost and deferred debt discounts
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
Share-based Compensation expenses [Abstract]
Share-Based Payment Arrangement, Noncash Expense [Abstract]
Operating Lease Liabilities
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]
Effect of dilutive stock options and warrants (in shares)
Weighted Average Number of Shares Outstanding, Diluted, Adjustment
Accounts Receivable Allowances and Accruals [Roll Forward]
Accounts Receivable Allowances and Accruals [Roll Forward]
Accounts Receivable Allowances and Accruals
Number of shares issued in transaction (in shares)
Sale of Stock, Number of Shares Issued in Transaction
Aggregate payment
Revenues
Payables and Accruals [Abstract]
Payables and Accruals [Abstract]
Product and Service [Domain]
Product and Service [Domain]
Accrued Expenses
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]
Cash and cash equivalents:
Restricted Cash and Cash Equivalents [Abstract]
Inventories, net
Increase (Decrease) in Inventories
Research and development
Research and Development Expense [Member]
First 7 Months
First Seven Months [Member]
First Seven Months
Investing activities:
Net Cash Provided by (Used in) Investing Activities [Abstract]
Proprietary product sales, net
Proprietary Product Sales [Member]
The aggregate revenue generated from proprietary product sales.
Award Type [Axis]
Award Type [Axis]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Granted (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period
Document Quarterly Report
Document Quarterly Report
Pro rata portion of target bonus
Pro Rata Portion of Target Bonus
Pro Rata Portion of Target Bonus
Premium paid to retire debt
Premium paid to retire debt
Payment for Debt Extinguishment or Debt Prepayment Cost
Interest expense
Interest Expense
Unrecognized compensation costs of RSU awards
Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount
Loss on extinguishment of debt
Gain (Loss) on Extinguishment of Debt
Selling, general and administrative
General and Administrative Expense [Member]
Property and equipment, gross
Property, Plant and Equipment, Gross
Expected amortization
Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Less: imputed interest
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
License and royalty revenue
License and Royalty Revenue [Member]
The aggregate revenue generated from licensing and royalties.
Long-term Debt, Type [Domain]
Long-Term Debt, Type [Domain]
Entity File Number
Entity File Number
Loss Contingencies [Table]
Loss Contingencies [Table]
Liability related to the sale of future revenue, net
Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Noncurrent
Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Noncurrent
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Lease liabilities, current
Operating Lease, Liability, Current
Manufacture and supply revenue
Manufacture and Supply Revenue [Member]
The aggregate revenue generated from manufacture and supply.
Agreement term
Agreement Term
Agreement Term
Shares issued under employee stock purchase plan (in shares)
Stock Issued During Period, Shares, Employee Stock Purchase Plans
Amortization expense
Amortization of Intangible Assets
Entity Shell Company
Entity Shell Company
2026
Lessee, Operating Lease, Liability, to be Paid, Year Three
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment [Line Items]
Recent Accounting Pronouncements
New Accounting Pronouncements, Policy [Policy Text Block]
Intangible assets, net
Intangible assets, net
Finite-Lived Intangible Assets, Net
Counterparty Name [Domain]
Counterparty Name [Domain]
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents
Less: accumulated amortization
Finite-Lived Intangible Assets, Accumulated Amortization
Percentage of cash proceeds
Repurchase Offer, Percentage of Cash Proceeds Received
Repurchase Offer, Percentage of Cash Proceeds Received
2025
Lessee, Operating Lease, Liability, to be Paid, Year Two
Trade receivables
Accounts Receivable, before Allowance for Credit Loss
Variable lease expense
Variable Lease, Cost
Operating lease expense
Operating Lease, Cost
Costs of common stock issued under public equity offering
Adjustments to Additional Paid in Capital, Stock Issued, Own-share Lending Arrangement, Issuance Costs
Common stock, shares issued (in shares)
Common Stock, Shares, Issued
Vested (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Option Indexed to Issuer's Equity, Type [Domain]
Option Indexed to Issuer's Equity, Type [Domain]
Severance costs
Severance Costs
Deferred revenue, current
Contract with Customer, Liability, Current
Research and development, project duration
Research and Development, Project Duration
Research and Development, Project Duration
Security Exchange Name
Security Exchange Name
Long-term debt
Total
Long-Term Debt
Consulting fee (in dollars per month)
Consulting Fee
Consulting Fee
Interest expense related to the sale of future revenue, net
Interest Expense, Sale of Future Revenues
Interest Expense, Sale of Future Revenues
Minimum annual royalty receivable
Minimum Annual Royalty Receivable
Minimum annual royalty receivable by the entity for the use of its rights and property by another party.
Consideration received on sale of stock
Sale of Stock, Consideration Received on Transaction
Selling, general and administrative
Selling, General and Administrative Expense
Material Agreements
Collaborative Arrangement Disclosure [Text Block]
Stock options
Employee Stock Option [Member]
Interest expense related to the sale of future revenue, net
Interest expense related to the sale of future revenue
Interest Expense, Sale of Future Revenues (Excluding Amortization)
Interest Expense, Sale of Future Revenues (Excluding Amortization)
Unrecognized compensation cost, recognition period
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Total costs and expenses
Costs and Expenses
Maximum
Maximum [Member]
Comprehensive income (loss)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]
Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]
Document Type
Document Type
Loans payable, net
Loans Payable, Noncurrent
Entity Address, Address Line One
Entity Address, Address Line One
License & Supply Agreement
License & Supply Agreement [Member]
License & Supply Agreement
Antidilutive Securities, Name [Domain]
Antidilutive Securities, Name [Domain]
Subsequent Event [Table]
Subsequent Event [Table]
Share-Based Compensation
Share-Based Payment Arrangement [Text Block]
Warrants
Warrants Disclosure [Text Block]
The entire disclosure for warrants.
Basis of Presentation
Basis of Accounting, Policy [Policy Text Block]
Other, net
Other Noncash Income (Expense)
Senior secured notes due 2025 - second additional offering
Second Additional Offering [Member]
The second additional offering of the loan agreement.
Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Real estate and personal property taxes
Taxes Payable, Current
Subsequent event
Subsequent Event [Member]
Supplemental agreement with Indivior
Supplemental Agreement with Indivior [Member]
The supplemental commercial exploitation agreement with Indivior.
Customer concentration risk
Customer Concentration Risk [Member]
Components of Identifiable Intangible Assets
Schedule of Finite-Lived Intangible Assets [Table Text Block]
Income Statement [Abstract]
Income Statement [Abstract]
Common stock issued (in shares)
Common Stock issued upon public equity offering (in shares)
Stock Issued During Period, Shares, New Issues
Title of 12(b) Security
Title of 12(b) Security
Litigation settlement, amount awarded from other party
Litigation Settlement, Amount Awarded from Other Party
Warrants and Rights Note Disclosure [Abstract]
Warrants and Rights Note Disclosure [Abstract]
Sale of Future Revenue [Roll Forward]
Sale of Future Revenue [Roll Forward]
Sale of Future Revenue
Right to sell common stock, value
Right to Sell Common Stock, Value
Right to Sell Common Stock, Value
Unvested, at beginning of period (in dollars per share)
Unvested, at end of period (in dollars per share)
Unvested (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
License agreement term
License Agreement Term
License agreement term period.
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Abstract]
Sales Related Allowances and Accruals
Sales Related Allowances and Accruals [Table Text Block]
Tabular disclosure of valuation of sales allowance and accruals for receivables due a company that are expected to be uncollectible including a rollforward of the balance.
Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]
Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]
Trade and Other Receivables, Net
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]
Share-based Payment Arrangement [Abstract]
Share-Based Payment Arrangement [Abstract]
Entity Tax Identification Number
Entity Tax Identification Number
Inventories, net
Total inventory, net
Inventory, Net
Statistical Measurement [Axis]
Statistical Measurement [Axis]
Statistical Measurement [Axis]
Payments / credits
Accounts Receivable Allowances, Credits and payments
For an unclassified balance sheet, a valuation of sales allowance for receivables related to credits due a company that are expected to be uncollectible.
Entity Interactive Data Current
Entity Interactive Data Current
Disaggregation of Revenue [Table]
Disaggregation of Revenue [Table]
MAM Pangolin Royalty , LLC
Marathon Pangolin Royalty LLC [Member]
Marathon Pangolin Royalty LLC
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Inventory Disclosure [Abstract]
Inventory Disclosure [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Accumulated deficit
Retained Earnings (Accumulated Deficit)
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Abstract]
Exercised, forfeited, expired (in dollars per share)
Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Forfeitures And Expirations In Period WeightedAverageExercisePrice
Weighted average price of options that were either exercised, forfeited or expired.
Revenue Recognition and Performance Obligations
Revenue from Contract with Customer [Policy Text Block]
Equity Unit Purchase Agreements
Equity Unit Purchase Agreements [Member]
Principal amount
Debt Instrument, Face Amount
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Current assets:
Assets, Current [Abstract]
Leases [Abstract]
Leases [Abstract]
Entity Address, State or Province
Entity Address, State or Province
Counterparty Name [Axis]
Counterparty Name [Axis]
License agreement with Sunovion Pharmaceuticals, Inc. upfront
License Agreement with Sunovion Pharmaceuticals, Inc. Upfront [Member]
The license agreement made with sunovion pharmaceuticals, inc. advance payments.
Public equity
Public equity [Member]
Public equity
Operating activities:
Net Cash Provided by (Used in) Operating Activities [Abstract]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Class of Warrant or Right [Domain]
Class of Warrant or Right [Domain]
Expected amortization in 2024
Finite-Lived Intangible Asset, Expected Amortization, Year One
Issuance [Axis]
Issuance [Axis]
Issuance
Share-based Compensation Expense
Share-Based Payment Arrangement, Cost by Plan [Table Text Block]
Common stock, shares outstanding (in shares)
Common Stock, Shares, Outstanding
Senior secured notes due 2025
Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]
A debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.
Trade and other receivables, net
Increase (Decrease) in Accounts and Other Receivables
Other
Stockholders' Equity, Other
Number of leases
Number of Operating Leases
Number of operating leases.
Lincoln Park agreement
Lincoln Park Agreement [Member]
Lincoln Park Agreement
Beginning balance (in shares)
Ending balance (in shares)
Shares, Outstanding
Common stock, par value (in dollars per share)
Common Stock, Par or Stated Value Per Share
Sale of Stock [Axis]
Sale of Stock [Axis]
Net cash used for investing activities
Net Cash Provided by (Used in) Investing Activities
Customer [Domain]
Customer [Domain]
Inventory, Net
Schedule of Inventory, Current [Table Text Block]
Number of Options
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]
Debt Instrument [Axis]
Debt Instrument [Axis]
Effective income tax rate
Effective Income Tax Rate Reconciliation, Percent
Repayment of debt
Repayments of Debt
Total operating lease liabilities
Operating Lease, Liability
Credit Facility [Axis]
Credit Facility [Axis]
Debt Maturity
Schedule of Maturities of Long-Term Debt [Table Text Block]
Total liabilities
Liabilities
Expected volatility
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate
Exercisable at end of period (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price
Prepaid expenses and other assets
Increase (Decrease) in Prepaid Expense and Other Assets
Property and Equipment, Net
Property, Plant and Equipment Disclosure [Text Block]
Deferred revenue
Contract with Customer, Liability, Noncurrent
Accrued Expenses
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
Debt Disclosure [Abstract]
Debt Disclosure [Abstract]
Long-Lived Tangible Asset [Domain]
Long-Lived Tangible Asset [Domain]
Earnings Per Share [Abstract]
Earnings Per Share [Abstract]
Subsequent Event [Line Items]
Subsequent Event [Line Items]
Trade and other receivables, net
Trade and other receivables, net
Trade and other receivables, net
Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade and other receivables).
Common stock ,$0.001 par value. Authorized 250,000,000 shares; 61,615,959 and 54,827,734 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively
Common Stock, Value, Issued
Repurchase price percentage
Debt Instrument, Redemption Price, Percentage
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Manufacture and supply
Manufacturing and supply [Member]
Primary financial statement caption encompassing Manufacturing and supply expense.
Senior notes
Senior Notes [Member]
Receivable
Contract with Customer, Receivable, after Allowance for Credit Loss
Total current assets
Assets, Current
Revenue from Contract with Customer [Abstract]
Supplemental disclosures of cash flow information:
Supplemental Cash Flow Information [Abstract]
Litigation Case [Domain]
Litigation Case [Domain]
Entity Filer Category
Entity Filer Category
Statement [Table]
Statement [Table]
Current Fiscal Year End Date
Current Fiscal Year End Date
Intangible Assets, Net
Goodwill and Intangible Assets Disclosure [Text Block]
Concentrations of risk
Concentration Risk, Percentage
Sale of Future Revenue
Sale of Future Revenue [Text Block]
Sale of Future Revenue
Granted (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Geographic Areas, Revenues from External Customers [Abstract]
Geographic Areas, Revenues from External Customers [Abstract]
Packaging material
Inventory Packing Material Gross
Amount of packaging materials expected to be sold within one year or operating cycle, if longer.
Cash payment representing 90 days of base pay
Cash Payment Representing 90 Days of Base Pay
Cash Payment Representing 90 Days of Base Pay
Proceeds from shares issued under employee stock purchase plan
Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised
Net cash provided by (used for) operating activities
Net Cash Provided by (Used in) Operating Activities
Other
Other Accrued Liabilities, Current
Furniture and fixtures
Furniture and Fixtures [Member]
Interest rate
Debt Instrument, Interest Rate, Stated Percentage
Statement of Financial Position [Abstract]
Statement of Financial Position [Abstract]
Proceeds from warrant exercises
Proceeds from Warrant Exercises
Issuance [Domain]
Issuance [Domain]
Issuance
Total stockholders’ deficit
Beginning balance
Ending balance
Equity, Attributable to Parent
Schedule of Finite-Lived Intangible Assets [Table]
Schedule of Finite-Lived Intangible Assets [Table]
Haisco Pharmaceutical Group Co., Ltd, upfront payment
Haisco Pharmaceutical Group Co., Ltd, Upfront Payment [Member]
Haisco Pharmaceutical Group Co., Ltd, Upfront Payment
New Warrants
New Warrants [Member]
New Warrants
Deferred revenue
Increase (Decrease) in Deferred Revenue
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Duration of payment [Axis]
Duration of payment [Axis]
Duration of payment
Finite-Lived Intangible Assets, Major Class Name [Domain]
Finite-Lived Intangible Assets, Major Class Name [Domain]
Concentration Risk Type [Axis]
Concentration Risk Type [Axis]
Expected term (years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term
Subsequent Events [Abstract]
Subsequent Events [Abstract]
Long-Lived Tangible Asset [Axis]
Long-Lived Tangible Asset [Axis]
Depreciation, amortization, and impairment
Depreciation, Depletion and Amortization, Nonproduction
Stock issued during period, conversion of convertible securities (in shares)
Stock Issued During Period, Shares, Conversion of Convertible Securities
Other Non-current Assets
Other Assets Disclosure [Text Block]
Provision
Accounts Receivable Allowances, Provision (Reversal) Related to Sales
For an unclassified balance sheet, a valuation of sales allowance for receivables related to sales due a company that are expected to be uncollectible.
Entity Emerging Growth Company
Entity Emerging Growth Company
Put option
Put Option [Member]
Finished goods
Inventory, Finished Goods, Gross
Net proceeds from issuance of initial notes, warrants and first offer rights
Net Proceeds from Issuance of Initial Notes, Warrants and First Offer Rights
The net cash inflow associated with the amount received from issuance of initial notes, warrants and first offer rights.
Effective annual interest rate
Debt Instrument, Interest Rate, Effective Percentage
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Document Fiscal Period Focus
Document Fiscal Period Focus
2024
Lessee, Operating Lease, Liability, to be Paid, Year One
Accrued expenses and other liabilities
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Antidilutive Securities [Axis]
Antidilutive Securities [Axis]
Outstanding (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-based compensation
Share-Based Payment Arrangement, Noncash Expense
Common Stock
Common Stock [Member]
Material Agreements [Abstract]
Material Agreements [Abstract]
City Area Code
City Area Code
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Product and Service [Axis]
Product and Service [Axis]
Net Earnings (Loss) Per Share
Earnings Per Share [Text Block]
Income Statement Location [Domain]
Income Statement Location [Domain]
Royalty
Royalty [Member]
Duration of payment [Domain]
Duration of payment [Domain]
Duration of payment [Domain]
Document Fiscal Year Focus
Document Fiscal Year Focus
Geographical [Domain]
Geographical [Domain]
Minimum
Minimum [Member]
Property and equipment, net
Total property and equipment, net
Property, Plant and Equipment, Net
Stock Option Activity
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Finite-Lived Intangible Assets by Major Class [Axis]
Finite-Lived Intangible Assets by Major Class [Axis]
Statement of Cash Flows [Abstract]
Statement of Cash Flows [Abstract]
Assets
Assets [Abstract]
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets Disclosure [Abstract]
Proceeds from common stock issued under private equity offering, net
Proceeds from Issuance of Long-Term Debt
Payments for taxes on share-based compensation
Payment, Tax Withholding, Share-Based Payment Arrangement
Net cash (used for) provided by financing activities
Net Cash Provided by (Used in) Financing Activities
Lessee, Lease, Description [Line Items]
Lessee, Lease, Description [Line Items]
License agreement with Sunovion Pharmaceuticals, Inc.
License Agreement with Sunovion Pharmaceuticals, Inc. [Member]
The license agreement made with sunovion pharmaceuticals, inc.
Contingencies
Commitments and Contingencies Disclosure [Text Block]
Accumulated Deficit
Retained Earnings [Member]
Total liabilities and stockholders’ deficit
Liabilities and Equity
Other income/ (expenses):
Nonoperating Income (Expense) [Abstract]
Other non-current assets
Total other non-current assets
Other Assets, Noncurrent
Risk-free interest rate
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Earnings (loss) per share attributable to common stockholders - basic (in dollars per share)
Earnings Per Share, Basic
Right-of-use assets, net
Operating Lease, Right-of-Use Asset
Unrecognized compensation expense related to non-vested stock options
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Schedule of Long-term Debt Instruments [Table]
Schedule of Long-Term Debt Instruments [Table]
Shares issued under employee stock purchase plan
Stock Issued During Period, Value, Employee Stock Purchase Plan
Accounting Policies [Abstract]
Accounting Policies [Abstract]
Sale of Stock [Domain]
Sale of Stock [Domain]
Remainder 2023
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
Warrants issued (in shares)
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Existing Warrants
Existing Warrants [Member]
Existing Warrants
Summary of Other Non-current Assets
Schedule of Other Assets, Noncurrent [Table Text Block]
Remaining amount available for offering
Sale Of Stock, Remaining Amount Available For Offering
Sale Of Stock, Remaining Amount Available For Offering
Entity Address, City or Town
Entity Address, City or Town
Proceeds from refinancing of debt
Proceeds from Issuance of Debt
Document Transition Report
Document Transition Report
Contract and other receivables
Other Receivables, Gross, Current
Purchased intangible
Technology-Based Intangible Assets [Member]
Co-development and research fees
Co-Development and Research Fees [Member]
The aggregate revenue generated from Co-development and research fees.
Accounts payable
Increase (Decrease) in Accounts Payable
Common stock, shares authorized (in shares)
Common Stock, Shares Authorized
Assertio Holdings, Inc
Assertio Holdings, Inc [Member]
Assertio Holdings, Inc
Neurelis, Inc. v. Aquestive Therapeutics, Inc.
Neurelis, Inc. v. Aquestive Therapeutics, Inc. [Member]
Neurelis, Inc. v. Aquestive Therapeutics, Inc.
Raw material
Inventory, Raw Materials, Gross
Exercised, forfeited, expired (in shares)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercised,Forfeitures and Expirations in Period
For presentations that combine terminations, the number of shares under options that were exercised, cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Abstract]
Adjustments to reconcile net loss to net cash used for operating activities:
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Inducement equity, common stock options outstanding (in shares)
Inducement Equity, Common Stock Options Outstanding, Shares
Inducement Equity, Common Stock Options Outstanding, Shares
Equity distribution agreement
Equity Distribution Agreement [Member]
Equity Distribution Agreement
Additions charged to expense
Accounts Receivable, Credit Loss Expense (Reversal)
Additional paid-in capital
Additional Paid in Capital
Forfeited (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Subsequent Event Type [Axis]
Subsequent Event Type [Axis]
Prepaid expenses and other current assets
Prepaid Expense and Other Assets, Current
Forfeited (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Shares of common stock
Shares of Common Stock Entitled to Purchasers by Pre-funded Warrants
Shares of Common Stock Entitled to Purchasers by Pre-funded Warrants
Less: allowance for doubtful accounts
Allowance for doubtful accounts at beginning of the period
Allowance for doubtful accounts at end of the period
Accounts Receivable, Allowance for Credit Loss
2024
Long-Term Debt, Maturity, Year One
Share price (in dollars per share)
Share Price
Severance period
Severance Period
Severance Period
Entity Registrant Name
Entity Registrant Name
Common Stock Warrants
Common Stock Warrants [Member]
Common Stock Warrants
Document Period End Date
Document Period End Date
Option Indexed to Issuer's Equity, Type [Axis]
Option Indexed to Issuer's Equity, Type [Axis]
Less: accumulated depreciation and amortization
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Proceeds from sale of future revenue
Proceeds From Sale of Future Revenues, Net
Proceeds From Sale of Future Revenues, Net
Revenue from Contract with Customer Benchmark
Revenue from Contract with Customer Benchmark [Member]
Hypera
Hypera [Member]
Hypera
Warrant exercises
Warrant exercises [Member]
Warrant exercises
12.5% Senior Secured Notes [Abstract]
Senior Secured Notes [Abstract]
Redemption percentage of debt under change of control provisions
Redemption percentage of debt under change of control provisions
Redemption percentage of debt under change of control provisions.
Entity Central Index Key
Entity Central Index Key
Subsidiary or equity method investee, cumulative percentage ownership limitation after all transactions
Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership Limitation After All Transactions
Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership Limitation After All Transactions
Amortization of debt issuance costs and discounts
Amortization expense, deferred debt issuance costs and debt discounts
Amortization of Debt Issuance Costs and Discounts
Risks and Uncertainties
Concentration Risk Disclosure [Text Block]
Class of Warrant or Right [Axis]
Class of Warrant or Right [Axis]
Share-based compensation expenses
Share-Based Payment Arrangement, Expense
Intangible assets, gross
Finite-Lived Intangible Assets, Gross
Income taxes
Income Tax Expense (Benefit)
Ex-United States
Non-US [Member]
Write-downs charged against the allowance
Accounts Receivable, Allowance for Credit Loss, Writeoff
Accrued compensation
Employee-related Liabilities, Current
Number of installments
Number Of Installments
Number Of Installments
Financial Instruments – Fair Value Measurements
Fair Value Disclosures [Text Block]
Repayment of debt principal including lease liabilities
Payments for loan acquisition costs
Payments of Financing Costs
Monetization Agreement
Monetization Agreement [Member]
Monetization Agreement
Disaggregation of Revenue
Disaggregation of Revenue [Table Text Block]
Securities purchase agreement
Securities Purchase Agreement [Member]
Securities Purchase Agreement
Common stock issued, value
Stock Issued During Period, Value, New Issues
Inventories, Net
Inventory Disclosure [Text Block]
Risks and Uncertainties [Abstract]
Risks and Uncertainties [Abstract]
Revenues
Royalties related to the sale of future revenue
Revenue from Contract with Customer, Excluding Assessed Tax
Long-term Debt, Type [Axis]
Long-Term Debt, Type [Axis]
Amendment Flag
Amendment Flag
Estimated discount rate
Lessee, Operating Lease, Discount Rate
Ninth through Eighteenth Month
Ninth through Eighteenth Month [Member]
Ninth through Eighteenth Month
Finite-Lived Intangible Assets, Net [Abstract]
Finite-Lived Intangible Assets, Net [Abstract]
License agreement with Sunovion Pharmaceuticals, Inc milestones
License Agreement with Sunovion Pharmaceuticals, Inc Milestones [Member]
The license agreement made with sunovion pharmaceuticals, inc. milestones.
Performance Share Activity
Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block]
Cash and cash equivalents
Cash and Cash Equivalents, at Carrying Value
Cash payments for interest
Interest Paid, Excluding Capitalized Interest, Operating Activities
Days of base pay
Days of Base Pay
Days of Base Pay
Accrued balances - trade and other receivables, net
Less: sales-related allowances
Accounts Receivable Allowances and Accruals, Trade and Other Receivables, Net
For an unclassified balance sheet, a valuation of sales allowance for receivables due a company that are expected to be uncollectible, classified within trade and other receivables, net.
Credit Facility [Domain]
Credit Facility [Domain]
Coverage duration
Coverage duration
Coverage duration
Useful Lives
Property, Plant and Equipment, Useful Life
Liability related to the sale of future revenue, current
Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Current
Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Current
Leasehold improvements
Leasehold Improvements [Member]
Weighted average common shares outstanding - diluted (in shares)
Weighted-average number of common shares - diluted (in shares)
Weighted Average Number of Shares Outstanding, Diluted
Fair value of warrants
Warrants Not Settleable in Cash, Fair Value Disclosure
Sale of stock, remaining value authorized for issuance
Sale Of Stock, Remaining Value Authorized For Issuance
Sale Of Stock, Remaining Value Authorized For Issuance
Costs and expenses:
Operating Expenses [Abstract]
Revenue and Trade Receivables, Net
Revenue from Contract with Customer [Text Block]
Capital expenditures
Payments to Acquire Property, Plant, and Equipment
Proceeds from debt, contingent on additional milestones
Contingent Monetization Agreement, Milestone Payment
Contingent Monetization Agreement, Milestone Payment
At-the-market offering, amendment no. 1
At The Market Offering, Amendment One [Member]
At The Market Offering, Amendment One
Additional Paid-in Capital
Additional Paid-in Capital [Member]
Total assets
Assets
Loss Contingencies [Line Items]
Loss Contingencies [Line Items]
Cover [Abstract]
Cover [Abstract]
Atnahs Pharma UK Limited
Atnahs Pharma UK Limited [Member]
Atnahs Pharma UK Limited
Additional borrowing capacity
Debt Instrument, Additional Borrowing Capacity
Amount of debt that can be borrowed in addition to initial notes.
Subsequent Events
Subsequent Events [Text Block]
Share-based compensation expense
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
Amortization of issuance costs
Amortization of Debt Issuance Costs
Current portion
Liabilities, Sale of Future Royalties, Current
Liabilities, Sale of Future Royalties, Current
United States
UNITED STATES
Other non-current liabilities
Other Liabilities, Noncurrent
Vested (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Total future lease payments
Lessee, Operating Lease, Liability, to be Paid
Construction in progress
Construction in Progress [Member]
Subsidiary, Sale of Stock [Line Items]
Subsidiary, Sale of Stock [Line Items]
Net (decrease) increase in cash and cash equivalents
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Financing activities:
Net Cash Provided by (Used in) Financing Activities [Abstract]
Equity Component [Domain]
Equity Component [Domain]
Debt Instrument [Line Items]
Debt Instrument [Line Items]
Weighted average common shares outstanding - basic (in shares)
Weighted-average number of common shares – basic (in shares)
Weighted Average Number of Shares Outstanding, Basic
Entity Current Reporting Status
Entity Current Reporting Status
Concentration Risk Type [Domain]
Concentration Risk Type [Domain]
Loss from operations
Operating Income (Loss)
Concentration Risk Benchmark [Axis]
Concentration Risk Benchmark [Axis]
Proceeds from issuance and exercise of warrants
Proceeds from Issuance and Exercise of Warrants
Proceeds from Issuance and Exercise of Warrants
Proceeds from common stock issued under public equity offering, net
Proceeds from Issuance Initial Public Offering
Vested and expected to vest at end of period (in shares)
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments, Other Than Options Grants, in Shares
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments, Other Than Options Grants, Estimated Grant Date in shares
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Statement [Line Items]
Statement [Line Items]
Concentration Risk [Table]
Concentration Risk [Table]
Sale of stock, aggregate offering price
Sale of Stock, Aggregate Offering Price
Sale of Stock, Aggregate Offering Price
Vested or expected to vest at end of period (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Reclassifications
Accounts Receivable Allowances, Reclassifications
Accounts Receivable Allowances, Reclassifications
Atnahs Pharma UK Limited, Amended Agreement
Atnahs Pharma UK Limited, Amended Agreement [Member]
Atnahs Pharma UK Limited, Amended Agreement